A Small but Significantly Greater Incidence of Inflammatory Heart Disease Identified After Vaccination for Severe Acute Respiratory Syndrome Coronavirus 2

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being administered on an unprecedented scale. Assessing the risks of side effects is needed to aid clinicians in early detection and treatment. This study examined the risk of inflammatory heart disease, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Knowlton, Kirk U, Knight, Stacey, Muhlestein, Joseph B, Le, Viet T, Horne, Benjamin D, May, Heidi T, Stenehjem, Edward A, Anderson, Jeffrey L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755376/
https://www.ncbi.nlm.nih.gov/pubmed/35141346
http://dx.doi.org/10.1093/ofid/ofab663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755376/
https://www.ncbi.nlm.nih.gov/pubmed/35141346
http://dx.doi.org/10.1093/ofid/ofab663

Ejemplares similares